Articles
AI, Data & Technology October 28, 2024

Blueprint of Hope: The Evolution of 3D Printing in Renal Transplantation
The field of renal regenerative medicine is rapidly evolving, with 3D bioprinting set to transform ESKD treatment and improve transplant outcomes.

AI, Data & Technology October 21, 2024

Redefining Clinical Excellence in Spinal Care Through AI: The Rise of Machine Learning in Diagnosis and Prognosis
As AI continues to evolve, its role in spinal care will likely expand.

AI, Data & Technology June 5, 2024

Data Deluge in Modern Healthcare: Navigating the Big Data Ocean
While big clinical data is characterized by its volume, variety, velocity, and veracity, several barriers limit its effective exchange.

Click Here To View More Article(s) Under This Category
Interviews
Reports
Events
Suppliers

Chronic & Debilitating Diseases

Chronic & Debilitating Diseases December 8, 2021

The Obesity Epidemic: Pharmaceutical Responses?

The growing obesity epidemic is a call to action by pharma and society are large; what are the responses?

Chronic & Debilitating Diseases November 18, 2021

Novel Treatments in Alzheimer’s Disease

With still no definitive treatment for Alzheimer’s Disease, new treatment candidates on the horizon look promising.

Chronic & Debilitating Diseases June 2, 2021

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June the FDA may approve Biogen Alzheimer’s drug, Aducanumab, which aims to slow the disease. But data concerns and FDA ‘closeness’ spell trouble.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings

Newsletter signup!

Want the latest headlines, thought pieces, whitepapers and more delivered straight to your inbox?

About Us

PharmaFeatures provides thought-leading interviews, industry reports and innovative daily content on the newest trends and breaking news across life sciences. In addition to clients within the pharmaceutical space, PharmaFeatures tailors to readers in biotechnology, clinical research, bioinformatics and more.

Information

Articles
Interviews
Reports
Events
Suppliers

Strategy Meetings

R&D
Clinical
Manufacturing

Helpful Links

Contact Us

Search for

Search Result(0)

<< View More

Search for

Search Result(0)

AI, Data & Technology

Bioinformatics & Multiomics

Biomanufacturing

Cell & Gene Therapy

Chemistry, Manufacturing & Controls

Chronic & Debilitating Diseases

Clinical Operations

Clinical Trial Supply Chain

Drug Discovery Biology

Featured

Immunology & Oncology

Infectious Diseases & Vaccinology

Interviews

Leadership, Trends & Investments

Manufacturing & Logistics

Medicinal Chemistry & Pharmacology

Neuroscience & Neuropharmacology

Pathophysiology & Experimental Medicine

Pharmacovigilance

Precision Medicine

Regulatory Affairs

Reports

Sleep, Nutrition & Exercise

<< View More

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...

Necessary

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Blueprint of Hope: The Evolution of 3D Printing in Renal Transplantation

Redefining Clinical Excellence in Spinal Care Through AI: The Rise of Machine Learning in Diagnosis and Prognosis

Data Deluge in Modern Healthcare: Navigating the Big Data Ocean

Chronic & Debilitating Diseases

The Obesity Epidemic: Pharmaceutical Responses?

Novel Treatments in Alzheimer’s Disease

First Potential Alzheimer’s Drug on the Brink of FDA Approval